He, Xuexin <br/><br/>
A pharmacokinetic and safety study of single dose intravenous combretastatin A4 phosphate in Chinese patients with refractory solid tumours.  [electronic resource] 

 -  British journal of clinical pharmacology  Jun 2011 
 - 860-70 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2125 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2125.2011.03928.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents, Phytogenic--adverse effects<br/>Asian People<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Stilbenes--adverse effects<br/>Treatment Outcome